These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature. Sherwin J; Heath T; Watt K Clin Ther; 2016 Sep; 38(9):1976-94. PubMed ID: 27553752 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients. Hahn J; Choi JH; Chang MJ J Clin Pharm Ther; 2017 Dec; 42(6):661-671. PubMed ID: 28948652 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive Guidance for Antibiotic Dosing in Obese Adults. Meng L; Mui E; Holubar MK; Deresinski SC Pharmacotherapy; 2017 Nov; 37(11):1415-1431. PubMed ID: 28869666 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants. Roberts JK; Stockmann C; Constance JE; Stiers J; Spigarelli MG; Ward RM; Sherwin CM Clin Pharmacokinet; 2014 Jul; 53(7):581-610. PubMed ID: 24871768 [TBL] [Abstract][Full Text] [Related]
6. Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: A structured review. Alobaid AS; Hites M; Lipman J; Taccone FS; Roberts JA Int J Antimicrob Agents; 2016 Apr; 47(4):259-68. PubMed ID: 26988339 [TBL] [Abstract][Full Text] [Related]
7. Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury. Cota JM; FakhriRavari A; Rowan MP; Chung KK; Murray CK; Akers KS Clin Ther; 2016 Sep; 38(9):2016-31. PubMed ID: 27586127 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial Agent Dosing in Infants. Johnson JK; Laughon MM Clin Ther; 2016 Sep; 38(9):1948-60. PubMed ID: 27473383 [TBL] [Abstract][Full Text] [Related]
9. Impact of hospital guideline for weight-based antimicrobial dosing in morbidly obese adults and comprehensive literature review. Polso AK; Lassiter JL; Nagel JL J Clin Pharm Ther; 2014 Dec; 39(6):584-608. PubMed ID: 25203631 [TBL] [Abstract][Full Text] [Related]
10. Optimisation of antimicrobial dosing based on pharmacokinetic and pharmacodynamic principles. Hoo GSR; Liew YX; Kwa AL Indian J Med Microbiol; 2017; 35(3):340-346. PubMed ID: 29063877 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive guidance for antibiotic dosing in obese adults: 2022 update. Meng L; Mui E; Ha DR; Stave C; Deresinski SC; Holubar M Pharmacotherapy; 2023 Mar; 43(3):226-246. PubMed ID: 36703246 [TBL] [Abstract][Full Text] [Related]
12. Applying pharmacokinetic/pharmacodynamic principles for optimizing antimicrobial therapy during continuous renal replacement therapy. Honore PM; Jacobs R; De Waele E; Spapen HD Anaesthesiol Intensive Ther; 2017; 49(5):412-418. PubMed ID: 29171000 [TBL] [Abstract][Full Text] [Related]
14. Antimicrobial pharmacokinetics and dosing in critically ill adults receiving prolonged intermittent renal replacement therapy: A systematic review. Grewal A; Thabet P; Dubinsky S; Purkayastha D; Wong K; Marko R; Hiremath S; Hutton B; Kanji S Pharmacotherapy; 2023 Nov; 43(11):1206-1220. PubMed ID: 37596844 [TBL] [Abstract][Full Text] [Related]
15. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity. Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of Commonly Used Antimicrobials in Critically Ill Adults During Extracorporeal Membrane Oxygenation: A Systematic Review. Duceppe MA; Kanji S; Do AT; Ruo N; Cavayas YA; Albert M; Robert-Halabi M; Zavalkoff S; Dupont P; Samoukovic G; Williamson DR Drugs; 2021 Jul; 81(11):1307-1329. PubMed ID: 34224115 [TBL] [Abstract][Full Text] [Related]
17. The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections. Tängdén T; Ramos Martín V; Felton TW; Nielsen EI; Marchand S; Brüggemann RJ; Bulitta JB; Bassetti M; Theuretzbacher U; Tsuji BT; Wareham DW; Friberg LE; De Waele JJ; Tam VH; Roberts JA; Intensive Care Med; 2017 Jul; 43(7):1021-1032. PubMed ID: 28409203 [TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients. Maseda E; Grau S; Luque S; Castillo-Mafla MP; Suárez-de-la-Rica A; Montero-Feijoo A; Salgado P; Gimenez MJ; García-Bernedo CA; Gilsanz F; Roberts JA Crit Care; 2018 Apr; 22(1):94. PubMed ID: 29655372 [TBL] [Abstract][Full Text] [Related]
19. Combatting the Rising Tide of Antimicrobial Resistance: Pharmacokinetic/Pharmacodynamic Dosing Strategies for Maximal Precision. Chua HC; Tse A; Smith NM; Mergenhagen KA; Cha R; Tsuji BT Int J Antimicrob Agents; 2021 Mar; 57(3):106269. PubMed ID: 33358761 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and pharmacodynamic considerations in antimicrobial therapy for sepsis. Fujii M; Karumai T; Yamamoto R; Kobayashi E; Ogawa K; Tounai M; Lipman J; Hayashi Y Expert Opin Drug Metab Toxicol; 2020 May; 16(5):415-430. PubMed ID: 32238005 [No Abstract] [Full Text] [Related] [Next] [New Search]